Skip to content
healthcare.dev

PHENAGIL

NDC 58552-322, PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE, tablet, from Gil Pharmaceutical Corp.

Product NDC
58552-322
Status
Listed
Labeler
Gil Pharmaceutical Corp
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58552-322 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1
  • CHLORPHENIRAMINE MALEATE3.5 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
58552-322-0158552032201100 TABLET in 1 BOTTLE (58552-322-01)
58552-322-025855203220212 POUCH in 1 BOX (58552-322-02) / 2 TABLET in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58552-322 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58552-322 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58552-322. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.